Adjunctive Use of Hyaluronic Acid in Multiple Coronally Advanced Flap
The Adjunctive Use of Hyaluronic Acid for the Treatment of Multiple Adjacent Gingival Recessions With Coronally Advanced Flap Plus Xenogeneic Collagen Matrix: a Randomized Clinical Trial
1 other identifier
interventional
40
1 country
1
Brief Summary
The primary aim of this study is to evaluate whether the effect of HA in combination with XCM for the treatment of MAGRs with a multiple coronally advanced flap technique (mCAF) achieves better results than the XCM with mCAF alone in terms of recession reduction (primary outcome) and other secondary root coverage outcomes (e.g. complete root coverage, mean root coverage). Moreover, this study aims to compare secondary clinical variables (e.g. keratinized tissue width (KTW) changes, probing pocket depth (PPD) changes, volumetric gain (VG), etc.), also with a digital approach, the patient-reported outcome measures (PROMs e.g. pain, swelling, bleeding) and lastly the expression of molecular mediators of tissue healing/regeneration. The hypothesis of this study is that at 6 months and 1 year follow-up the mCAF with XCM+HA is superior to the mCAF with only XCM in terms of recessions reduction and secondary clinical variables, including PROMs.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started May 2022
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 3, 2022
CompletedFirst Submitted
Initial submission to the registry
May 6, 2022
CompletedFirst Posted
Study publicly available on registry
May 11, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 10, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
September 10, 2024
CompletedMay 19, 2022
May 1, 2022
2.4 years
May 6, 2022
May 11, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Mean Recession Reduction (RecRed)
Mean changes in mm in recession depth between baseline and 1-year
6 months; 1 year
Secondary Outcomes (4)
Complete Root Coverage (CRC)
6 months; 1 year
Mean Root Coverage (MRC)
6 months; 1 year
Keratinised tissue height (KTH) changes
6 months; 1 year
Post-operative morbidity (pain, swelling, discomfort)
14 days
Study Arms (2)
Xenogenic collagen matrix (XCM) + Hyaluronic acid (HA)
EXPERIMENTALMultiple coronally advanced flap technique (mCAF) with the use of a XCM in combination with local application of a HA gel
Xenogenic collagen matrix (XCM)
ACTIVE COMPARATORMultiple coronally advanced flap technique (mCAF) with the use of a XCM
Interventions
After local anaesthesia, mCAF technique with two releasing vertical incisions will be performed. XCM will be adapted on the root surfaces and positioned at the level of the cemento-enamel junction and HA gel will be applied.
After local anaesthesia, mCAF technique with two releasing vertical incisions will be performed. XCM will be adapted on the root surfaces and positioned at the level of the cemento-enamel junction.
Eligibility Criteria
You may qualify if:
- At least 18 years old and able to sign informed consent
- At least 2 adjacent teeth with RT1 and/or RT2 gingival recessions without interproximal exposure of the CEJ (interdental gingival recession), at least one with a depth of ≥2mm with indication for root coverage treatment
- A minimum of 4 adjacent teeth (including the ones to be treated) in the region of interest
- Available to attend study related procedures (including follow-up visits)
You may not qualify if:
- Systemic diseases/medications which could influence the outcome of the therapy (e.g., uncontrolled diabetes mellitus);
- Current smokers (self-reported, any type of smoking), users of chewing tobacco, and drug/alcohol abusers;
- Pregnant or nursing women;
- History of previous periodontal surgery (mucogingival or other) on the teeth to be included;
- Furcation involvement in the teeth to be included;
- Presence of severe tooth malposition, rotation or clinically significant extrusion in the teeth to be treated;
- Presence of fixed or removable prosthesis in the area to be treated
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Turin
Turin, 10126, Italy
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 6, 2022
First Posted
May 11, 2022
Study Start
May 3, 2022
Primary Completion
September 10, 2024
Study Completion
September 10, 2024
Last Updated
May 19, 2022
Record last verified: 2022-05